<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25368830</article-id>
      <article-id pub-id-type="pmc">4215420</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2014.34.6.487</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="heading">
            <subject>Clinical Microbiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Discovery of a Fluoroquinolone-Resistant <italic>Serratia marcescens</italic> Clinical Isolate without Quinolone Resistance-Determining Region Mutations</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yang</surname>
            <given-names>Haifei</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Chen</surname>
            <given-names>Guosheng</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Jun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yanyan</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Lifen</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ye</surname>
            <given-names>Ying</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Jiabin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</aff>
      <aff id="A2"><label>2</label>Institute of Bacterial Resistance, Anhui Medical University, Hefei, Anhui, China.</aff>
      <aff id="A3"><label>3</label>Anhui Center for Surveillance of Bacterial Resistance, Hefei, Anhui, China.</aff>
      <aff id="A4"><label>4</label>Department of Center Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</aff>
      <author-notes>
        <corresp>Corresponding author: Jiabin Li. Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Jixi road 218, Hefei, Anhui, China. Tel: +86-551-62922713, Fax: +86-551-62922281, <email>lijiabin948@vip.sohu.com</email></corresp>
        <corresp>Co-corresponding author: Ying Ye. Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Jixi road 218, Hefei, Anhui, China. Tel: +86-551-62922713, Fax: +86-551-62922281, <email>yeying2@139.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <volume>34</volume>
      <issue>6</issue>
      <fpage>487</fpage>
      <lpage>488</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>20</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <funding-group>
        <award-group>
          <funding-source country="CN">National Natural Science Foundation of China</funding-source>
          <award-id>81172737</award-id>
          <award-id>30972631</award-id>
        </award-group>
        <award-group>
          <funding-source country="CN">Natural Science Foundation of Anhui Province</funding-source>
          <award-id>11040606Q23</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <p>Sir,</p>
    <p><italic>Serratia marcescens</italic>, once considered to be an innocuous and non-pathogenic organism, is now an important cause of hospital-acquired infections. This organism is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis, and wound infections [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. <italic>S. marcescens</italic> infections are difficult to treat because of high resistance to a wide variety of antibiotics, including cephalosporins, fluoroquinolones, and aztreonam [<xref rid="B2" ref-type="bibr">2</xref>].</p>
    <p>Fluoroquinolones are broad-spectrum bactericidal antimicrobial agents that are used to treat various bacterial infections. Although <italic>S. marcescens</italic> infections are frequently treated with fluoroquinolones, the incidence of fluoroquinolone resistance continues to increase in clinical settings in China [<xref rid="B2" ref-type="bibr">2</xref>]. Fluoroquinolone resistance is mainly caused by chromosomal mutations affecting the quinolone resistance-determining region (QRDR) of <italic>gyrA</italic> and <italic>gyrB</italic>, which encode DNA gyrase subunits, and <italic>parC</italic> and <italic>parE</italic>, which encode topoisomerase IV subunits [<xref rid="B3" ref-type="bibr">3</xref>]. Moreover, plasmid-mediated quinolone resistance (PMQR) genes have been reported in gram-negative bacteria, including <italic>S. marcescens</italic>, and include the <italic>qnr</italic>, <italic>qep</italic>, and <italic>oqx</italic> systems [<xref rid="B4" ref-type="bibr">4</xref>]. The major cause of fluoroquinolone resistance is chromosomal mutation. The acquisition of PMQR genes alone results in a low level of fluoroquinolone resistance and does not lead to minimum inhibitory concentrations (MICs) exceeding the threshold of these agents [<xref rid="B3" ref-type="bibr">3</xref>].</p>
    <p>We isolated a <italic>S. marcescens</italic> strain, designated as GN0780, from the wound drainage fluid of a 66-yr-old male patient who had femoral fractures and was admitted to the Department of Orthopedics at the People's Hospital of Huangshan (Huangshan, China) in 2011. The MICs of ciprofloxacin (CIP), levofloxacin (LVX), gatifloxacin (GAT), and nalidixic acid (NAL) exceeded the resistance thresholds proposed by the Clinical and Laboratory Standards Institute (2012) (<xref ref-type="table" rid="T1">Table 1</xref>) [<xref rid="B5" ref-type="bibr">5</xref>]. Surprisingly, direct DNA sequencing of the QRDRs did not reveal any mutations in <italic>gyrA</italic>, <italic>gyrB</italic>, <italic>parC</italic>, or <italic>parE</italic> when compared with the wild-type strain (<xref ref-type="table" rid="T1">Table 1</xref>). We then screened for the PMQR genes <italic>qnrA</italic>, <italic>qnrB</italic>, <italic>qnrS</italic>, <italic>qnrC</italic>, <italic>qnrD</italic>, <italic>aac</italic>(<italic>6'</italic>)-<italic>Ib</italic>-<italic>cr</italic>, <italic>qepA</italic>, and <italic>oqxAB</italic> by PCR. None of the PMQR genes were identified in <italic>S. marcescens</italic> GN0780 (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
    <p>Quinolones were introduced into clinical practice in the late 1960s. Although quinolone resistance was described soon after their introduction, the transmission mechanism of quinolone resistance was confirmed only in 1998. To date, five different PMQR mechanisms have been described in the literature, including target protection (Qnr), quinolone modification (AAC(6')-Ib-cr), plasmid-encoded efflux systems (e.g., QepA or OqxAB), effect on bacterial growth rates, and natural transformation. Although PMQRs usually result in only a slight increase in the MICs of quinolones, they show an additive effect and may thus facilitate the acquisition of full quinolone resistance [<xref rid="B6" ref-type="bibr">6</xref>].</p>
    <p>Several clinical bacterial isolates that have been reported to express phenotypic resistance do not exhibit corresponding genotypic mutations. This phenomenon has recently been studied in a clinical isolate of <italic>Escherichia coli</italic> HUE1 from Japan [<xref rid="B7" ref-type="bibr">7</xref>]. The authors suggested that the fluoroquinolone resistance in this HUE1 isolate, which does not have mutations in the QRDR, is caused by the coexistence of <italic>oqxAB</italic> and <italic>qnrS</italic>. OqxAB and QnrS increase the MIC of CIP by approximately 32-fold and 64-fold, respectively. However, other mechanisms may also be associated with fluoroquinolone resistance in HUE1.</p>
    <p>Chopra and Galande [<xref rid="B8" ref-type="bibr">8</xref>] isolated an Acinetobacter baumannii mutant, designated as strain AB-7, which exhibited a CIP MIC of 16 mg/L. However, no mutation was detected in QRDRs, and no PMQR genes were present in AB-7. Our findings are consistent with the case of AB-7; <italic>S. marcescens</italic> GN0780 showed no mutation in QRDRs, and no PMQR gene was detected. We speculate that other mechanisms may be associated with fluoroquinolone resistance in GN0780; therefore, further investigations are needed. Our findings suggest an exception to the well-accepted mechanism of resistance to fluoroquinolones. These results also underscore the need of achieving deeper understanding of the mechanisms of action and evolution of resistance to conventional antibiotics. In conclusion, we present the first report of fluoroquinolone resistance in <italic>S. marcescens</italic> lacking PMQR genes and mutations in QRDRs.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by a research grant from the National Natural Science Foundation of China (No. 81172737, 30972631) and the Natural Science Foundation of Anhui Province, China (No. 11040606Q23).</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahlen</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title><italic>Serratia</italic> infections: from military experiments to current practice</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2011</year>
          <volume>24</volume>
          <fpage>755</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="pmid">21976608</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Plasmid-mediated quinolone resistance in extended-spectrum-&#x3B2;-lactamase- and AmpC &#x3B2;-lactamase-producing <italic>Serratia marcescens</italic> in China</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2012</year>
          <volume>56</volume>
          <fpage>4529</fpage>
          <lpage>4531</lpage>
          <pub-id pub-id-type="pmid">22664965</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruiz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2003</year>
          <volume>51</volume>
          <fpage>1109</fpage>
          <lpage>1117</lpage>
          <pub-id pub-id-type="pmid">12697644</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strahilevitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jacoby</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Robicsek</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Plasmid-mediated quinolone resistance: a multifaceted threat</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>664</fpage>
          <lpage>689</lpage>
          <pub-id pub-id-type="pmid">19822894</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="book">
          <collab>Clinical and Laboratory Standards Institute</collab>
          <source>Performance standards for antimicrobial susceptibility testing, Twenty-Second Informational supplement, M100-S22</source>
          <publisher-loc>Wayne, PA</publisher-loc>
          <publisher-name>CLSI</publisher-name>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruiz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pons</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Transferable mechanisms of quinolone resistance</article-title>
          <source>Int J Antimicrob Agents</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>196</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="pmid">22831841</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yokota</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Okubo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A fluoroquinolone-resistant <italic>Escherichia coli</italic> clinical isolate without quinolone resistance-determining region mutations found in Japan</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2011</year>
          <volume>55</volume>
          <fpage>3964</fpage>
          <lpage>3965</lpage>
          <pub-id pub-id-type="pmid">21670180</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chopra</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A fluoroquinolone-resistant <italic>Acinetobacter baumannii</italic> without the quinolone resistance-determining region mutations</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2011</year>
          <volume>66</volume>
          <fpage>2668</fpage>
          <lpage>2670</lpage>
          <pub-id pub-id-type="pmid">21903661</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Fluoroquinolone susceptibility, QRDR mutations, and PMQRs in <italic>Serratia marcescens</italic> GN0780</p>
      </caption>
      <graphic xlink:href="alm-34-487-i001"/>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>None of the PMQR genes were identified in GN0780.</p>
          <p>Abbreviations: QRDR, quinolone-resistance determining region; PMQR, plasmid-mediated quinolone resistance; MIC, minimum inhibitory concentration; WT, wild type; CIP, ciprofloxacin; LVX, levofloxacin; GAT, gatifloxacin; NAL, nalidixic acid.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
